The 3 analysts offering 12-month price forecasts for Twist Bioscience Corp have a median target of 31.00, with a high estimate of 37.00 and a low estimate of 30.00. The median estimate represents a +29.87% increase from the last price of 23.87.
The current consensus among 4 polled investment analysts is to Buy stock in Twist Bioscience Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.87
Reporting Date Feb 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.